BICLUSTER_ID : UPREG-248
PATHOGENS /2/ : streptococcus pyogenes,helicobacter pylori
TARGETS /25/ : PDE4D, PPARD, LCN2, CCL20, CCL2, TNFRSF1B, HCK, CD80, GCH1, CCL5, SAT1, PIM1, IFNG, DNMT1, NFKB1, SELP, CD3E, XDH, HMOX1, JAK2, WARS, IL6, ICAM1, TLR2, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPPDE4D, CCL20, LCN2, CCL2, RELA, CCL7, IFNG, CXCL2, DNMT1, CSF2, PTX3, C1R, BIRC3, CXCL1, LIF, PLK2, WARS, CXCL5, IL6, C3, PBEF1, ZFP36, ICAM1
NETPATH IL 2 PATHWAY UPIL6ST, TNFRSF1B, RELA, RGS16, IL4R, GATA3, PIM1, IFNG, CSF2, BHLHB2, SLC30A1, IER3, NFKB1, KLF6, LIF, CSF1, IRF5, WARS, CD69, IL18R1, MAP3K7IP2, GADD45G, ARHGDIA, SAMHD1, IL6, ICAM1, PBEF1, IRF1, UPP1, PLAUR
GERY CEBP TARGETSGADD45B, LCN2, TRIB3, DDIT3, CD47, GCH1, PIM1, SAT1, XDH, HMOX1, JUNB, NR1D1, GADD45G, CXCL5, SAA3P, C3
NETPATH IL 4 PATHWAY DOWNCCL20, GADD45B, LITAF, CCL2, GBP2, NFKBIA, IL6, ICAM1, IRF1, CXCL2, TLR2
NETPATH KIT RECEPTOR PATHWAY UPHMOX1, JUNB, CCL2, RELA, IL6, CCL5, PIM1, CSF2, IER3
NETPATH B CELL RECEPTOR PATHWAY UPPSMB8, CCL2, DDIT3, HCK, TRAF1, IL4R, PTGES, CCL5, PIM1, DUSP8, MYD88, BIRC3, CD69, ELF4, FADD, CCR1, CXADR, ICAM1
NETPATH IL 5 PATHWAY UPPLSCR1, NFKB2, NFKBIE, CCL2, RELA, PIM1, NFE2L2, IER3, MYD88, CASP4, NFKB1, SELP, BIRC3, FADD, TBK1, C3, ICAM1, UPP1
NCI IL23PATHWAYNFKB1, NFKBIA, IL6, CXCL1, JAK2, CCL2, RELA
NCI IL12 2PATHWAYNFKB1, CD3E, GADD45B, JAK2, NFKB2, IL18R1, GADD45G, RELA, IFNG, B2M
NETPATH IL 9 PATHWAY UPLCN2, CCL2, JUNB, SELL, BCL3, CCL7, MRAS, PIM1
NETPATH IL 7 PATHWAY UPCXCL5, CXCL1, LITAF, CCL5, CXCL2, CD80
NCI IL6 7PATHWAYIL6ST, JAK2, CEBPD, JUNB, CEBPB, IRF1, HCK
NCI CHEMOKINE RECEPTORS BIND CHEMOKINESCCL25, CCL20, CCL5, CX3CL1
NETPATH IL 3 PATHWAY UPCCL7, CSF1, CCL2, PIM1
NETPATH IL 6 PATHWAY UPGADD45B, PPARD, CEBPD, JUNB, CEBPB, IGFBP4, BCL3, MAP3K8, ZFP36, IRF1, PIM1
SA MMP CYTOKINE CONNECTIONCSF1, SELL, TNFRSF1B
BIOCARTA STEM PATHWAY
TURJANSKI MAPK7 TARGETS
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
BIOCARTA IL6 PATHWAY
KEGG GRAFT VERSUS HOST DISEASE
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
LUI THYROID CANCER CLUSTER 4
HOFMANN CELL LYMPHOMA DN
NCI CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
NETPATH T CELL RECEPTOR PATHWAY DOWN
XU HGF TARGETS REPRESSED BY AKT1 UP
MUNSHI MULTIPLE MYELOMA UP
BROWNE INTERFERON RESPONSIVE GENES
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
REACTOME SIGNALING IN IMMUNE SYSTEM
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
BIOCARTA LAIR PATHWAY
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
SCHEIDEREIT IKK INTERACTING PROTEINS
OSADA ASCL1 TARGETS DN
BIOCARTA LYM PATHWAY
GILMORE CORE NFKB PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
TSAI RESPONSE TO IONIZING RADIATION
POOLA INVASIVE BREAST CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
BIOCARTA FREE PATHWAY
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
CORUM NFKB1-NFKB2-RELA-RELB COMPLEX
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
BIOCARTA RANKL PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
MCLACHLAN DENTAL CARIES UP
BROWNE HCMV INFECTION 8HR UP
ISHIKAWA STING SIGNALING
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
BIOCARTA NUCLEARRS PATHWAY
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
BIOCARTA HIVNEF PATHWAY
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
BIOCARTA MONOCYTE PATHWAY
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
WONG ENDMETRIUM CANCER UP
AMIT SERUM RESPONSE 120 MCF10A
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
NCI IL1PATHWAY
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
ZHAN MULTIPLE MYELOMA DN
REACTOME CD28 CO STIMULATION
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
WONG IFNA2 RESISTANCE UP
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
AMIT DELAYED EARLY GENES
HINATA NFKB TARGETS FIBROBLAST UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
CORUM MURR1-NFKAPPABP65-IKBA COMPLEX
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 0
MAINA HYPOXIA VHL TARGETS UP
AUJLA IL22 AND IL17A SIGNALING
NCI NFKAPPABATYPICALPATHWAYBCL3, RELA
CHIBA RESPONSE TO TSA
WALLACE PROSTATE CANCER RACE UP
NETPATH IL 7 PATHWAY DOWN
SIMBULAN UV RESPONSE NORMAL UP
AUNG GASTRIC CANCER
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
WIELAND UP BY HBV INFECTION
COATES MACROPHAGE M1 VS M2 DN
REACTOME CD28 DEPENDENT PI3K AKT SIGNALING
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
UROSEVIC RESPONSE TO IMIQUIMOD
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
KEGG JAK STAT SIGNALING PATHWAY
HARRIS HYPOXIA
TSAI DNAJB4 TARGETS UP
SCHAVOLT TARGETS OF TP53 AND TP63
DER IFN BETA RESPONSE UP
MORI PRE BI LYMPHOCYTE DN
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
GALI TP53 TARGETS APOPTOTIC UP
AMIT EGF RESPONSE 20 HELA
REACTOME INNATE IMMUNITY SIGNALING
MUELLER METHYLATED IN GLIOBLASTOMA
BASSO CD40 SIGNALING UP
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
BIOCARTA BLYMPHOCYTE PATHWAY
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
BIOCARTA TID PATHWAY
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
BIOCARTA CTL PATHWAY
KEGG LEISHMANIA INFECTION
DER IFN ALPHA RESPONSE UP
WU HBX TARGETS 1 UP
MILICIC FAMILIAL ADENOMATOUS POLYPOSIS UP
MCLACHLAN DENTAL CARIES DN
BIOCARTA DEATH PATHWAY
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ZHU CMV 8 HR UP
CORUM LMO4-GP130 COMPLEX
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
NCI IL27PATHWAY
FOSTER INFLAMMATORY RESPONSE LPS UP
ONDER CDH1 TARGETS 2 DN
REACTOME TOLL RECEPTOR CASCADES
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KEGG CHEMOKINE SIGNALING PATHWAY
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
REACTOME ACTIVATED TLR4 SIGNALLING
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
BIOCARTA TOLL PATHWAY
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
ZUCCHI METASTASIS DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
PRAMOONJAGO SOX4 TARGETS UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx1 mgepstreptococcus pyogenesGeneSet Name
0.00000 0.03192NETPATH_IL_1_PATHWAY_UP
0.02575 0.01602NETPATH_IL_2_PATHWAY_UP
0.00133 0.01652GERY_CEBP_TARGETS
0.00002 0.00471NETPATH_IL_4_PATHWAY_DOWN
0.00065 0.02708NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.01192 0.08745NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00021 0.03974NETPATH_IL_5_PATHWAY_UP
0.00589 0.00014NCI_IL23PATHWAY
0.05996 0.00000NCI_IL12_2PATHWAY
0.00013 0.00011NETPATH_IL_9_PATHWAY_UP
0.00294 0.04416NETPATH_IL_7_PATHWAY_UP
0.04616 0.00000NCI_IL6_7PATHWAY
0.05605 0.03180NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.03326 0.00095NETPATH_IL_3_PATHWAY_UP
0.00236 0.00001NETPATH_IL_6_PATHWAY_UP
0.01005 0.02244SA_MMP_CYTOKINE_CONNECTION
0.02542 0.03626BIOCARTA_STEM_PATHWAY
0.05499 0.11230TURJANSKI_MAPK7_TARGETS
0.00155 0.16684BIOCARTA_NFKB_PATHWAY
0.00517 0.17839MAHAJAN_RESPONSE_TO_IL1A_UP
0.02454 0.00482BIOCARTA_IL6_PATHWAY
0.02385 0.01019KEGG_GRAFT_VERSUS_HOST_DISEASE
0.02414 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.09639 0.00032REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.11465 0.00784TENEDINI_MEGAKARYOCYTE_MARKERS
0.00000 0.02304LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00015 0.00032LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.08041 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.09109 0.02400LUI_THYROID_CANCER_CLUSTER_4
0.09678 0.00273HOFMANN_CELL_LYMPHOMA_DN
0.07965 0.17774NCI_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.15073 0.13300NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.07397 0.14382XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.15913 0.19933MUNSHI_MULTIPLE_MYELOMA_UP
0.07388 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.11415THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.13041 0.00018REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.10179 0.13253TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.11960 0.00204LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00718 0.00201BIOCARTA_LAIR_PATHWAY
0.00002 0.05930HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.07713 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00005 0.02604KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.07688 0.03169SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.10172 0.03178OSADA_ASCL1_TARGETS_DN
0.02445 0.05182BIOCARTA_LYM_PATHWAY
0.00003 0.06138GILMORE_CORE_NFKB_PATHWAY
0.01257 0.10005NUYTTEN_EZH2_TARGETS_UP
0.00000 0.02575DUTTA_APOPTOSIS_VIA_NFKB
0.00508 0.02653TSAI_RESPONSE_TO_IONIZING_RADIATION
0.13876 0.00003POOLA_INVASIVE_BREAST_CANCER_UP
0.00157 0.00616DIRMEIER_LMP1_RESPONSE_EARLY
0.03795 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.16521 0.00394KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00018 0.00007REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.07886 0.10876BIOCARTA_FREE_PATHWAY
0.09618 0.18510RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.02900 0.15921CORUM_NFKB1-NFKB2-RELA-RELB_COMPLEX
0.02466 0.00012NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.02627 0.08751BIOCARTA_RANKL_PATHWAY
0.01988 0.01028NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00018 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.02400 0.14519BROWNE_HCMV_INFECTION_8HR_UP
0.10515 0.08747ISHIKAWA_STING_SIGNALING
0.00006 0.00568FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.17072 0.01561LEE_LIVER_CANCER_E2F1_UP
0.03788 0.00445TAVOR_CEBPA_TARGETS_UP
0.18090 0.06921BIOCARTA_NUCLEARRS_PATHWAY
0.00002 0.00000GAURNIER_PSMD4_TARGETS
0.02029 0.00113HELLER_SILENCED_BY_METHYLATION_UP
0.05535 0.14458BIOCARTA_HIVNEF_PATHWAY
0.10562 0.03392NETPATH_TNF_ALPHA_PATHWAY_UP
0.03341 0.00039MARKEY_RB1_CHRONIC_LOF_DN
0.03750 0.05989BIOCARTA_MONOCYTE_PATHWAY
0.17326 0.05508SMID_BREAST_CANCER_LUMINAL_B_DN
0.00307 0.06782ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00257 0.01538GESERICK_TERT_TARGETS_DN
0.19450 0.00076WONG_ENDMETRIUM_CANCER_UP
0.00289 0.09332AMIT_SERUM_RESPONSE_120_MCF10A
0.12111 0.04834CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.06190 0.19947NCI_IL1PATHWAY
0.07216 0.00000REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.09984 0.03170REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.00063 0.01128VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.01130 0.00074BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00000 0.01876GEISS_RESPONSE_TO_DSRNA_UP
0.11276 0.19908GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.15849 0.01687SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.18696 0.00392ZHAN_MULTIPLE_MYELOMA_DN
0.18360 0.00386REACTOME_CD28_CO_STIMULATION
0.00000 0.00455TIAN_TNF_SIGNALING_VIA_NFKB
0.02445 0.02106HUMMEL_BURKITTS_LYMPHOMA_DN
0.01293 0.06342ZHU_CMV_ALL_UP
0.01726 0.00011KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03341 0.16600WONG_IFNA2_RESISTANCE_UP
0.00719 0.17781CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.00013 0.11718AMIT_DELAYED_EARLY_GENES
0.00000 0.14412HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.02218 0.00010KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00032 0.08281NOJIMA_SFRP2_TARGETS_UP
0.00126 0.12534CHEN_HOXA5_TARGETS_6HR_UP
0.00725 0.01557MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.07692 0.01265SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.07621 0.19151CORUM_MURR1-NFKAPPABP65-IKBA_COMPLEX
0.09307 0.07680YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.03916 0.11594MAINA_HYPOXIA_VHL_TARGETS_UP
0.01124 0.02059AUJLA_IL22_AND_IL17A_SIGNALING
0.00461 0.01125NCI_NFKAPPABATYPICALPATHWAY
0.04619 0.16189CHIBA_RESPONSE_TO_TSA
0.17667 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.14176 0.03184NETPATH_IL_7_PATHWAY_DOWN
0.02203 0.01756SIMBULAN_UV_RESPONSE_NORMAL_UP
0.05812 0.10878AUNG_GASTRIC_CANCER
0.11957 0.13522DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.17121 0.00000WIELAND_UP_BY_HBV_INFECTION
0.07585 0.01553COATES_MACROPHAGE_M1_VS_M2_DN
0.19433 0.01599REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING
0.13491 0.02986RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.19498 0.00001UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.09986 0.01836CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.09614 0.00074KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00027 0.15102HARRIS_HYPOXIA
0.02725 0.00073TSAI_DNAJB4_TARGETS_UP
0.10952 0.14369SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.04581 0.00032DER_IFN_BETA_RESPONSE_UP
0.13814 0.06972MORI_PRE_BI_LYMPHOCYTE_DN
0.00015 0.19929DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.01118 0.04180GALI_TP53_TARGETS_APOPTOTIC_UP
0.02197 0.10732AMIT_EGF_RESPONSE_20_HELA
0.10693 0.00979REACTOME_INNATE_IMMUNITY_SIGNALING
0.17512 0.00116MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00077 0.00023BASSO_CD40_SIGNALING_UP
0.10243 0.00000NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.04862 0.13526MARZEC_IL2_SIGNALING_UP
0.00011 0.00021SOUCEK_MYC_TARGETS
0.09108 0.02720BIOCARTA_BLYMPHOCYTE_PATHWAY
0.00624 0.02682WU_HBX_TARGETS_2_DN
0.00002 0.01593MAHADEVAN_RESPONSE_TO_MP470_UP
0.00095 0.01314KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00325 0.02287BIOCARTA_TID_PATHWAY
0.00031 0.00099LIANG_SILENCED_BY_METHYLATION_2
0.00067 0.00038DAUER_STAT3_TARGETS_UP
0.04722 0.00074BIOCARTA_CTL_PATHWAY
0.00031 0.00061KEGG_LEISHMANIA_INFECTION
0.14451 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.02309 0.18465WU_HBX_TARGETS_1_UP
0.09286 0.11442MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP
0.00030 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.05146 0.02608BIOCARTA_DEATH_PATHWAY
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00937 0.05533GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00261 0.06323BROWNE_HCMV_INFECTION_4HR_UP
0.03193 0.03561WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00019ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.03178 0.00624PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.01261 0.00367ZHU_CMV_8_HR_UP
0.11946 0.08772CORUM_LMO4-GP130_COMPLEX
0.05381 0.19333BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.10038 0.00027NCI_IL27PATHWAY
0.00587 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.03557 0.16233ONDER_CDH1_TARGETS_2_DN
0.08039 0.12834REACTOME_TOLL_RECEPTOR_CASCADES
0.12773 0.02844INGA_TP53_TARGETS
0.00215 0.09492HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.01185 0.07017SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.12202 0.01866KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.03185 0.04007KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.01647 0.01558BIOCARTA_GRANULOCYTES_PATHWAY
0.07552 0.19099REACTOME_ACTIVATED_TLR4_SIGNALLING
0.04632 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.07974 0.04449DASU_IL6_SIGNALING_UP
0.01652 0.14957BIOCARTA_TOLL_PATHWAY
0.02386 0.12740AMIT_EGF_RESPONSE_120_MCF10A
0.00000 0.05507GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.07010 0.18519GOUYER_TATI_TARGETS_UP
0.00723 0.01684ZUCCHI_METASTASIS_DN
0.01985 0.01025BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00000 0.19931PRAMOONJAGO_SOX4_TARGETS_UP